EECP Improves Quality of Life and Symptoms in Congestive Heart Failure Patients 體外反搏治療改善 充血性心臟衰竭 患者的症狀及生活素質

Source From 資料來源 : https://pubmed.ncbi.nlm.nih.gov/20043608/

EECP Improves Quality of Life and Symptoms in Congestive Heart Failure Patients

Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.

「使用增強型反搏療法治療難治性心絞痛和 充血性心臟衰竭 」

體外反搏治療(EECP)是經過美國食品和藥物管理局(FDA)批准的非藥物治療方法,用於治療對醫學管理無效的心絞痛和 充血性心臟衰竭 。EECP能改善這些患者的生活質量、症狀和運動持續時間。

×